Literature DB >> 15649857

In vitro comparison of nebulised budesonide (Pulmicort Respules) and beclomethasone dipropionate (Clenil per Aerosol).

A Vaghi1, E Berg, S Liljedahl, J O Svensson.   

Abstract

This study compared the in vitro performance of two inhaled corticosteroid products for nebulisation, Pulmicort Respules(budesonide 0.5 mg/mL) and Clenil) per Aerosol (beclomethasone dipropionate (BDP) 0.4 mg/mL). Each product was used in combination with three different nebulisers (2 mL/test, 5 min run time) and the dose to the lungs was determined according to standard methods. The shape of the suspended particles in each product was studied using scanning electron microscopy (SEM). Overall, a higher fine particle dose was achieved with Pulmicort Respules versus Clenil per Aerosol, with estimated dose to the lungs of 8-14 and 3-6% of nominal dose, respectively. SEM showed that budesonide particles were small, typically approximately 2-3 microm in diameter, whereas those of BDP were needle-shaped and up to approximately 10 microm long. The more favourable particle shape and size of suspended budesonide may explain the higher fine particle dose with Pulmicort Respules versus Clenil per Aerosol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15649857     DOI: 10.1016/j.pupt.2004.10.004

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  7 in total

1.  Drug delivery systems in children.

Authors:  Stephen Lowis
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 2.  Expert consensus on nebulization therapy in pre-hospital and in-hospital emergency care.

Authors: 
Journal:  Ann Transl Med       Date:  2019-09

3.  Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers.

Authors:  Amir Amani; Peter York; Henry Chrystyn; Brian J Clark
Journal:  AAPS PharmSciTech       Date:  2010-07-24       Impact factor: 3.246

4.  Rehydrated lyophilized rifampicin-loaded mPEG-DSPE formulations for nebulization.

Authors:  Juma Masoud Abdulla Abdulla; Yvonne Tze-Fung Tan; Yusrida Darwis
Journal:  AAPS PharmSciTech       Date:  2010-04-20       Impact factor: 3.246

5.  Solubilization of beclomethasone dipropionate in sterically stabilized phospholipid nanomicelles (SSMs): physicochemical and in vitro evaluations.

Authors:  Mohanad Naji Sahib; Shaymaa Abdalwahed Abdulameer; Yusrida Darwis; Kok Khiang Peh; Yvonne Tze Fung Tan
Journal:  Drug Des Devel Ther       Date:  2012       Impact factor: 4.162

6.  Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations.

Authors:  Mohanad Naji Sahib; Yusrida Darwis; Kok Khiang Peh; Shaymaa Abdalwahed Abdulameer; Yvonne Tze Fung Tan
Journal:  Int J Nanomedicine       Date:  2011-10-14

7.  Evaluation of a Nanodispersion Formulation Prepared through Microfluidic Reactors for Pulmonary Delivery of Budesonide Using Nebulizers.

Authors:  Hany Sm Ali; Peter York; Amir Amani; Nicholas Blagden
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.